Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease

The purpose of this study was to assess the five-year treatment effects of a short course of intravenous immunoglobulin (IVIG) in subjects with mild cognitive impairment (MCI) due to Alzheimer disease (AD).

Source: BMC Neuroscience - August 6, 2021 Category: Neuroscience Authors: Shawn Kile, William Au, Carol Parise, Kimberley Rose, Tammy Donnel, Andrea Hankins, Yvonne Au, Matthew Chan and Azad Ghassemi Tags: Research article Source Type: research